Frutarom Switzerland Ltd. Health Business Unit, appointed Matthias H. Kreuter, Ph.D., as its new Global Chief Scientific Officer (CSO), effective January 1, 2015. 

Kreuter headed Frutarom’s Pharmaceutical Business Division from 1990 to 2003. During this time, Dr. Kreuter invented the Hyperpure Technology and developed the EFLA® Topline extracts. He returns to Frutarom after performing a wide range of leadership responsibilities, primarily in phyto-pharmaceuticals, phytochemical product development and R&D.

Dr. Kreuter holds a PhD in physiological chemistry and cancer pharmacology from the Faculty of Medicine at Johannes Gutenberg University, Mainz, Germany, as well as a degree in pharmacy, from the Faculty of Pharmacy. An inventor with 18 patents to his credit, he is also a respected author and has published a large number of books and articles in international science journals, including Drug Research, Cell, Int. Journal of Oncology, European Journal of Clinical Nutrition.

Kreuter will report to Holger Riemensperger, GM of the Global Business Unit, Health, for Frutarom, and use his vast experience in the phytopharmaceutical business to contribute to the strategic development of the company in this vital core business.

“I’m excited to welcome Dr. Kreuter to our team,” acknowledges Riemensperger. “Dr. Kreuter’s skill set, bolstered by his many years of experience, will help us lead Frutarom to the next level via high-impact growth—not only in the dietary supplements industry, but also in the food, beverage and pharmaceuticals industries.”

“It is with great pleasure I rejoin Frutarom Health team and take on the challenge of contributing my knowledge and experience toward developing a winning botanical extracts line for this dynamic marketplace,” says Kreuter. “I’m proud that Frutarom’s healthy ingredients are backed up by extensive scientific research, and will do my part to help Frutarom continue to set new trends and offer innovative natural ingredients to the marketplace.”